Company Filing History:
1 out of 51 
1 out of 50 
1 out of 50 
Years Active: 2019
Title: Alshaimaa Alhallaj: Innovator in Leukemia Treatment
Introduction
Alshaimaa Alhallaj is a notable inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of medical science, particularly in the treatment of leukemia. His innovative approach focuses on gene expression and its implications for patient care.
Latest Patents
Alhallaj holds a patent for a method of treating leukemia based on gene expression of clock genes. This method involves obtaining plasma samples from a patient at two different time points. It includes measuring the gene expression levels of core clock genes and peripheral clock genes. The effectiveness of a treatment is determined by analyzing the correlation of these gene expression levels, allowing for tailored patient care.
Career Highlights
Throughout his career, Alshaimaa Alhallaj has worked with esteemed organizations such as National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Alhallaj has collaborated with professionals like Mohamed Boudjelal and Ahmed Al Askar. These partnerships have enhanced his research and development efforts in the medical field.
Conclusion
Alshaimaa Alhallaj is a pioneering inventor whose work in leukemia treatment showcases the potential of gene expression in personalized medicine. His contributions are paving the way for advancements in patient care and treatment efficacy.